Back | Next |
home / stock / nvcn / nvcn message board
Subject | By | Source | When |
---|---|---|---|
FDA, needs to stop doing the white house | Crapola2theleft | investorshub | 12/31/2021 3:50:05 PM |
Crazy crazy crazy | zeusgodmd | investorshub | 12/28/2021 9:09:01 PM |
They invested 60 million in this company 5 | zeusgodmd | investorshub | 12/27/2021 1:56:27 PM |
Stays down here will get bought out cheap. | zeusgodmd | investorshub | 12/27/2021 1:55:11 PM |
P U a bunch of $NVCN. Placed another | Crapola2theleft | investorshub | 12/15/2021 3:40:20 PM |
If it where Boston scientific or Edward would | zeusgodmd | investorshub | 12/13/2021 9:41:17 PM |
Remember how the FDA told Fred too make | Crapola2theleft | investorshub | 12/13/2021 4:27:45 PM |
I like your response time. However, your wrong, | Crapola2theleft | investorshub | 12/13/2021 4:06:23 PM |
Think stock should be at a minimum 4$ | zeusgodmd | investorshub | 12/13/2021 3:51:03 PM |
zeusgodmd, your last post was on 10/22/21. Wondering | Crapola2theleft | investorshub | 12/13/2021 3:47:13 PM |
whytestocks: $NVCN News Article - The National Institute for Health and Care Excellence of The Unite | whytestocks | investorshangout | 11/24/2021 6:00:54 PM |
whytestocks: $NVCN News Article - The National Institute for Health and Care Excellence of the Unite | whytestocks | investorshangout | 11/24/2021 5:55:50 PM |
Maybe some news after hours coming | zeusgodmd | investorshub | 10/22/2021 7:40:49 PM |
whytestocks: $NVCN News Article - Neovasc Announces FDA Approval of COSIRA-II Clinical Trial | whytestocks | investorshangout | 09/16/2021 2:25:50 PM |
Looking strong today something must be getting ready | zeusgodmd | investorshub | 07/12/2021 11:59:18 PM |
That was a great run | zeusgodmd | investorshub | 06/11/2021 12:30:35 AM |
halted hmmm | saj | investorshub | 06/10/2021 7:13:10 PM |
I dont know what from maybe one of | zeusgodmd | investorshub | 06/03/2021 1:12:42 AM |
$NVCN nice lil pop in pre | saj | investorshub | 06/02/2021 1:13:58 PM |
This company can not catch a break. | zeusgodmd | investorshub | 05/21/2021 4:56:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...